Hill-Rom Holdings (NYSE:HRC) CFO Mark Guinan is leaving the medical device company to become finance chief for Quest Diagnostics (NYSE:DGX), the medical device company said today as it released preliminary 2nd-quarter results.
Batesville, Ind.-based Hill-Rom said it expects to post adjusted earnings per share of 40¢ on sales of roughly $424 million for its fiscal 3rd quarter.
Analysts on Wall Street are expecting Hill-Rom to post adjusted EPS of 50¢.
Treasurer Michael Macek will be Hill-Rom’s interim CFO until its external search for a replacement is complete, according to a press release.
"Mark has been a strong leader and valued contributor to Hill-Rom throughout his tenure," president & CEO John Greisch said in prepared remarks. "We have engaged an executive search consultant to conduct the process for identifying Mark’s successor as our chief financial officer, and will provide an update on the process when appropriate."
HRC shares were trading at $35.10 apiece as of about 3:40 p.m. today, up 1.4%.